,

NDFS13 BARDA Presentation: Partnering with the Biomedical Advanced Research and Development Authority

Dr. Joe Larsen of the Biomedical Advanced Research and Development Authority discussed current CBRN threats and BARDA’s role in developing and stockpiling countermeasures.

View Slide Deck

/0 Comments/by
You might also like
How Non-Dilutive Funding Can Extend Runway in BioPharma, Biotech, and Tech Bio Is Non-Dilutive Funding the Key to Extending Runway in Biopharma and Biotech?
National MS Society Presentation – Accelerating Translational R&D for Multiple Sclerosis
Non-dilutive funding leads to equity investment How Non-Dilutive Funding Leads to Equity Investment: The Story of Enalare
NDFS17 CIRM NDFS17 Video: CIRM Translation & Clinical Development Grants for Cell & Gene Therapy
NDFS17 BARDA NDFS17 Video: Non-dilutive funding at BARDA for medical countermeasure R&D
NDFS13 NINDS Presentation: Overview and Update on HHS SBIR/STTR Programs
NDFS17 Inflammatix NDFS17 Video: Inflammatix: Our Road to Success with Non-Dilutive Funding
Extension for Temporary AOI#14 (COVID-19) EZ BAA
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *